Risk Factors for Infection after Prostate Biopsy in the United States.
Aged
Biopsy
/ adverse effects
Cohort Studies
Humans
Male
Medicare
/ statistics & numerical data
Odds Ratio
Patient Admission
/ statistics & numerical data
Postoperative Complications
/ epidemiology
Prostate
/ pathology
Prostatic Neoplasms
/ diagnosis
Risk Factors
SEER Program
/ statistics & numerical data
Surgeons
/ statistics & numerical data
United States
/ epidemiology
Workload
/ statistics & numerical data
Journal
Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
02
08
2019
revised:
19
12
2019
accepted:
20
12
2019
pubmed:
4
1
2020
medline:
13
1
2022
entrez:
4
1
2020
Statut:
ppublish
Résumé
We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data from 2001 to 2015 and recorded 30-day infection rates and emergency department, hospital and, intensive care unit (ICU) admissions. We performed adjusted analyses to analyze the effect of age, demographic data, surgeon volume, rectal swab use, and biopsy year on infections. We found that the overall rate of postbiopsy infections increased from 2001 (5.9%) to 2007 (7.2%) but remained stable through 2015. Despite this, postbiopsy emergency room visits rose from 0.2% to 0.5% (95% confidence interval [CI] 0.2%-0.4%, P < .01), hospitalizations rose from 0.5% to 1.3% (95% CI 0.5%-1.0%, P < .01), and ICU admissions increased from 0.1% to 0.3% (95% CI 0.1%-0.3%, P < .01). Patients of surgeons who performed 25 biopsies per year had lower odds of postbiopsy infection (odds ratio 0.65; 95% CI 0.61-0.69) and a lower risk of hospitalization (odds ratio 0.50; 95% CI 0.43-0.59) as compared to patients of surgeons who performed one biopsy per year. Rectal swab use increased over the study period but remained low (1.8% in 2015). While the overall rate of postbiopsy infections has stabilized since 2007, admissions to the emergency room, hospital, and ICU continue to rise. Increased surgeon volume was associated with a decreased risk of infection.
Identifiants
pubmed: 31899233
pii: S0090-4295(19)31126-4
doi: 10.1016/j.urology.2019.12.023
pmc: PMC7549646
mid: NIHMS1626040
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
113-118Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA092629
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Can Urol Assoc J. 2010 Feb;4(1):E12-4
pubmed: 20174484
BJU Int. 2010 Oct;106(7):1017-20
pubmed: 20346055
J Urol. 2013 Jan;189(1 Suppl):S12-7; discussion S17-8
pubmed: 23234616
J Urol. 2004 Jan;171(1):346
pubmed: 14665920
J Urol. 2018 Aug;200(2):361-368
pubmed: 29574110
Eur Urol. 2017 Mar;71(3):353-365
pubmed: 27543165
J Urol. 2017 Nov;198(5):1046-1053
pubmed: 28487099
BJU Int. 2014 Feb;113(2):254-9
pubmed: 24053621
Prostate Cancer Prostatic Dis. 2008;11(2):207-8
pubmed: 18391939
Lancet. 2005 Feb 12-18;365(9459):548-9
pubmed: 15708081
J Infect. 1999 Mar;38(2):128-9
pubmed: 10342656
Eur Urol. 2012 Jun;61(6):1110-4
pubmed: 22244150
BJU Int. 2016 May;117(5):725-31
pubmed: 26709240
Urology. 2011 May;77(5):1035-41
pubmed: 21420152
Lancet. 2016 Jan 9;387(10014):176-87
pubmed: 26603922
J Urol. 2015 Aug;194(2):403-9
pubmed: 25896556
Urology. 2011 Sep;78(3):511-4
pubmed: 21782225
J Urol. 2017 Aug;198(2):329-334
pubmed: 28363690
Scand J Urol Nephrol. 2002;36(2):156-7
pubmed: 12028692
JAMA. 2018 May 8;319(18):1901-1913
pubmed: 29801017
Eur Urol. 2012 Sep;62(3):453-9
pubmed: 22575912
BJU Int. 2012 Jun;109(12):1781-5
pubmed: 22040349
Can J Urol. 2010 Apr;17(2):5135-7
pubmed: 20398457
BJU Int. 2012 Aug;110(3):369-74
pubmed: 22313996
Urology. 2009 Dec;74(6):1195-9
pubmed: 19811805
J Urol. 2011 Nov;186(5):1830-4
pubmed: 21944136